Status:
UNKNOWN
Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary Aspergillosis
Lead Sponsor:
Assiut University
Conditions:
Thymus and Activation Regulated Chemokine
Eligibility:
All Genders
Brief Summary
This study aims to assess the value of TARC in diagnosis of allergic Bronchopulmonary Aspergillosis.
Detailed Description
Allergic bronchopulmonary Aspergillosis (ABPA) is a pulmonary hypersensitivity disease mediated by an allergic response to Aspergillus fumigates. ABPA occurs in, 10% of cystic fibrosis (CF) patients a...
Eligibility Criteria
Inclusion
- • In this study patients referred from chest department for diagnosis of allergic pulmonary Aspergillosis will be included.
Exclusion
- • Pregnancy
- Lactating women
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2018
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03267394
Start Date
October 1 2017
End Date
November 1 2018
Last Update
August 30 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.